{"pmid":32391367,"pmcid":"PMC7191079","title":"The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.","text":["The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.","Front Med (Lausanne)","Briguglio, Matteo","Pregliasco, Fabrizio Ernesto","Lombardi, Giovanni","Perazzo, Paolo","Banfi, Giuseppe","32391367"],"journal":"Front Med (Lausanne)","authors":["Briguglio, Matteo","Pregliasco, Fabrizio Ernesto","Lombardi, Giovanni","Perazzo, Paolo","Banfi, Giuseppe"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391367","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3389/fmed.2020.00146","keywords":["covid-19","sars-cov-2","coronavirus","host pathogen interactions","infections","nutritional status","quality of health care","virulence"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666528579944448000,"score":9.490897,"similar":[{"pmid":32492197,"title":"SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.","text":["SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.","Nowadays, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused novel coronavirus disease (COVID-19) pandemic, is the worldwide challenge. The virus is highly contagious, and clinical consequences were very divers. It is estimated that if no effective action is taken, COVID-19 could plague 90% of the world's population and kill over 40 million people. So, it is essential to understand the virus pathogenicity and follow the preventive methods to control the high morbidity and mortality rates. Meanwhile our current knowledge of COVID-19 is still limited, despite hard efforts of scientists and clinicians during last few months. In this review article, we have collected the latest data about characteristics, pathogenesis, clinical manifestations, and diagnostic methods of SARS-CoV-2. This article is protected by copyright. All rights reserved.","J Med Virol","Lotfi, Melika","Rezaei, Nima","32492197"],"abstract":["Nowadays, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused novel coronavirus disease (COVID-19) pandemic, is the worldwide challenge. The virus is highly contagious, and clinical consequences were very divers. It is estimated that if no effective action is taken, COVID-19 could plague 90% of the world's population and kill over 40 million people. So, it is essential to understand the virus pathogenicity and follow the preventive methods to control the high morbidity and mortality rates. Meanwhile our current knowledge of COVID-19 is still limited, despite hard efforts of scientists and clinicians during last few months. In this review article, we have collected the latest data about characteristics, pathogenesis, clinical manifestations, and diagnostic methods of SARS-CoV-2. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lotfi, Melika","Rezaei, Nima"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492197","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26123","keywords":["2019-ncov","covid-19","clinical manifestations","sars-cov-2","virulence"],"topics":["Diagnosis"],"weight":1,"_version_":1668892169337831425,"score":79.43587},{"pmid":32449297,"title":"SARS-CoV-2 Virulence: Interplay of Floating Virus-Laden Particles, Climate, and Humans.","text":["SARS-CoV-2 Virulence: Interplay of Floating Virus-Laden Particles, Climate, and Humans.","With the emergence of COVID-19, it is important to address the possible scenarios of SARS-CoV-2 virulence. Although several researchers have addressed the possible mechanisms of enveloped virus transfection, for example, influenza, here, the relationship between exhaled virus laden-particles, the climate, and transfection probability is discussed by interpreting the findings of prior studies. Importantly, the higher probability of viral transfection in cold and dry public spaces such as near cold shelves of groceries is illustrated. Thus, additional protective measures in such spaces are recommended.","Adv Biosyst","Hosseini, Vahid","32449297"],"abstract":["With the emergence of COVID-19, it is important to address the possible scenarios of SARS-CoV-2 virulence. Although several researchers have addressed the possible mechanisms of enveloped virus transfection, for example, influenza, here, the relationship between exhaled virus laden-particles, the climate, and transfection probability is discussed by interpreting the findings of prior studies. Importantly, the higher probability of viral transfection in cold and dry public spaces such as near cold shelves of groceries is illustrated. Thus, additional protective measures in such spaces are recommended."],"journal":"Adv Biosyst","authors":["Hosseini, Vahid"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449297","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/adbi.202000105","keywords":["covid-19","sars-cov-2","climate","virulence","virus-laden particles"],"topics":["Prevention"],"weight":1,"_version_":1667785213967597569,"score":76.09721},{"pmid":32489698,"pmcid":"PMC7220294","title":"COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.","text":["COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.","The World health organization (WHO) declared Coronavirus disease 2019 (COVID-19) a global pandemic and a severe public health crisis. Drastic measures to combat COVID-19 are warranted due to its contagiousness and higher mortality rates, specifically in the aged patient population. At the current stage, due to the lack of effective treatment strategies for COVID-19 innovative approaches need to be considered. It is well known that host cellular miRNAs can directly target both viral 3'UTR and coding region of the viral genome to induce the antiviral effect. In this study, we did in silico analysis of human miRNAs targeting SARS (4 isolates) and COVID-19 (29 recent isolates from different regions) genome and correlated our findings with aging and underlying conditions. We found 848 common miRNAs targeting the SARS genome and 873 common microRNAs targeting the COVID-19 genome. Out of a total of 848 miRNAs from SARS, only 558 commonly present in all COVID-19 isolates. Interestingly, 315 miRNAs are unique for COVID-19 isolates and 290 miRNAs unique to SARS. We also noted that out of 29 COVID-19 isolates, 19 isolates have identical miRNA targets. The COVID-19 isolates, Netherland (EPI_ISL_422601), Australia (EPI_ISL_413214), and Wuhan (EPI_ISL_403931) showed six, four, and four unique miRNAs targets, respectively. Furthermore, GO, and KEGG pathway analysis showed that COVID-19 targeting human miRNAs involved in various age-related signaling and diseases. Recent studies also suggested that some of the human miRNAs targeting COVID-19 decreased with aging and underlying conditions. GO and KEGG identified impaired signaling pathway may be due to low abundance miRNA which might be one of the contributing factors for the increasing severity and mortality in aged individuals and with other underlying conditions. Further, in vitro and in vivo studies are needed to validate some of these targets and identify potential therapeutic targets.","Aging Dis","Fulzele, Sadanand","Sahay, Bikash","Yusufu, Ibrahim","Lee, Tae Jin","Sharma, Ashok","Kolhe, Ravindra","Isales, Carlos M","32489698"],"abstract":["The World health organization (WHO) declared Coronavirus disease 2019 (COVID-19) a global pandemic and a severe public health crisis. Drastic measures to combat COVID-19 are warranted due to its contagiousness and higher mortality rates, specifically in the aged patient population. At the current stage, due to the lack of effective treatment strategies for COVID-19 innovative approaches need to be considered. It is well known that host cellular miRNAs can directly target both viral 3'UTR and coding region of the viral genome to induce the antiviral effect. In this study, we did in silico analysis of human miRNAs targeting SARS (4 isolates) and COVID-19 (29 recent isolates from different regions) genome and correlated our findings with aging and underlying conditions. We found 848 common miRNAs targeting the SARS genome and 873 common microRNAs targeting the COVID-19 genome. Out of a total of 848 miRNAs from SARS, only 558 commonly present in all COVID-19 isolates. Interestingly, 315 miRNAs are unique for COVID-19 isolates and 290 miRNAs unique to SARS. We also noted that out of 29 COVID-19 isolates, 19 isolates have identical miRNA targets. The COVID-19 isolates, Netherland (EPI_ISL_422601), Australia (EPI_ISL_413214), and Wuhan (EPI_ISL_403931) showed six, four, and four unique miRNAs targets, respectively. Furthermore, GO, and KEGG pathway analysis showed that COVID-19 targeting human miRNAs involved in various age-related signaling and diseases. Recent studies also suggested that some of the human miRNAs targeting COVID-19 decreased with aging and underlying conditions. GO and KEGG identified impaired signaling pathway may be due to low abundance miRNA which might be one of the contributing factors for the increasing severity and mortality in aged individuals and with other underlying conditions. Further, in vitro and in vivo studies are needed to validate some of these targets and identify potential therapeutic targets."],"journal":"Aging Dis","authors":["Fulzele, Sadanand","Sahay, Bikash","Yusufu, Ibrahim","Lee, Tae Jin","Sharma, Ashok","Kolhe, Ravindra","Isales, Carlos M"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489698","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.14336/AD.2020.0428","keywords":["coronavirus","aging","micrornas"],"locations":["Australia","Wuhan"],"countries":["Australia","China"],"countries_codes":["AUS|Australia","CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668623433611608065,"score":66.35287},{"pmid":32056235,"pmcid":"PMC7166592","title":"Does SARS-CoV-2 has a longer incubation period than SARS and MERS?","text":["Does SARS-CoV-2 has a longer incubation period than SARS and MERS?","The outbreak of a novel coronavirus (SARS-CoV-2) since December 2019 in Wuhan, the major transportation hub in central China, became an emergency of major international concern. While several etiological studies have begun to reveal the specific biological features of this virus, the epidemic characteristics need to be elucidated. Notably, a long incubation time was reported to be associated with SARS-CoV-2 infection, leading to adjustments in screening and control policies. To avoid the risk of virus spread, all potentially exposed subjects are required to be isolated for 14 days, which is the longest predicted incubation time. However, based on our analysis of a larger dataset available so far, we find there is no observable difference between the incubation time for SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV), and middle east respiratory syndrome coronavirus (MERS-CoV), highlighting the need for larger and well-annotated datasets.","J Med Virol","Jiang, Xuan","Rayner, Simon","Luo, Min-Hua","32056235"],"abstract":["The outbreak of a novel coronavirus (SARS-CoV-2) since December 2019 in Wuhan, the major transportation hub in central China, became an emergency of major international concern. While several etiological studies have begun to reveal the specific biological features of this virus, the epidemic characteristics need to be elucidated. Notably, a long incubation time was reported to be associated with SARS-CoV-2 infection, leading to adjustments in screening and control policies. To avoid the risk of virus spread, all potentially exposed subjects are required to be isolated for 14 days, which is the longest predicted incubation time. However, based on our analysis of a larger dataset available so far, we find there is no observable difference between the incubation time for SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV), and middle east respiratory syndrome coronavirus (MERS-CoV), highlighting the need for larger and well-annotated datasets."],"journal":"J Med Virol","authors":["Jiang, Xuan","Rayner, Simon","Luo, Min-Hua"],"date":"2020-02-15T11:00:00Z","year":2020,"_id":"32056235","source":"PubMed","week":"20207|Feb 10 - Feb 16","doi":"10.1002/jmv.25708","keywords":["coronavirus","incubation","local infection/replication/spread","pandemic","virulence"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Prevention"],"weight":1,"_version_":1666138490858897408,"score":61.708405},{"pmid":32305438,"pmcid":"PMC7162762","title":"The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19.","text":["The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19.","J Am Acad Dermatol","Freeman, Esther E","McMahon, Devon E","Fitzgerald, Matthew E","Fox, Lindy P","Rosenbach, Misha","Takeshita, Junko","French, Lars E","Thiers, Bruce H","Hruza, George J","32305438"],"journal":"J Am Acad Dermatol","authors":["Freeman, Esther E","McMahon, Devon E","Fitzgerald, Matthew E","Fox, Lindy P","Rosenbach, Misha","Takeshita, Junko","French, Lars E","Thiers, Bruce H","Hruza, George J"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305438","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaad.2020.04.045","keywords":["covid-19","dermatology","outcomes research","public health","quality of health care","registries"],"topics":["Treatment"],"weight":1,"_version_":1666138493354508288,"score":61.05821}]}